Pfizer found a way to boost its ailing stock — agree on drug pricing with TrumpRxBy Mario Cazombo / September 30, 2025 Pfizer’s stock surged after CEO Albert Bourla announces an agreement with the Trump administration aimed at lowering drug prices in the U.S. and removing tariff uncertainty.
Book Review: The Financial Restructuring Tool Set August 6, 2025 / Book Reviews, Corporate Finance, Drivers of Value, Economics, Financial Statement Analysis, General
